Tanya Tekautz, M.D.
| Appointed: |
2006 |
| Gender: |
Female |
| Languages: |
English |
Brain Tumor and Neuro-Oncology Center
Pediatric Hematology and Oncology
Taussig Cancer Institute
Biographical Sketch
Tanya M. Tekautz, MD, is a Pediatric and Young Adult Neuro-Oncologist. She is board-certified in general pediatrics and pediatric hematology/oncology.
Clinical interests include treatments for pediatric and young adult high-grade brain tumors, atypical teratoid/rhabdoid tumors, low grade-glioma and designing therapeutic clinical trials for relapsed brain tumors in children and young adults.
Education & Fellowships
| Medical School: | University of Minnesota Medical School, Minneapolis, MN |
|
| Internship: | Baylor College of Medicine Affiliated Hospitals, Pediatrics, Houston, TX |
| Residency: | Baylor College of Medicine Affiliated Hospitals, Pediatrics, Houston, TX |
| Fellowship: | Saint Jude Children's Research Hospital, Pediatric Neurology/Oncology, Memphis, TN |
| Fellowship: | Saint Jude Children's Research Hospital, Pediatric Hematology/Oncology, Memphis, TN |
| Other Education: | (Undergraduate) University of Minnesota, Minneapolis, MN |
Certifications
Pediatric Hematology-Oncology
Pediatrics
Specialty Interests
Adult and pediatric brain and spine tumors, adult and pediatric brain tumors, adult and pediatric neuro-oncology, benign and malignant tumors of the brain and spinal cord, benign brain tumors (meningiomas, schwannomas), Brain Metastases, brain tumors, CNS metastatic disease, molecular biology of brain tumors clinical and translational trials, neuro-oncology, pediatric oncology, tumors of the brain and spine, childhood cancer, pediatric hematology/oncology.
Awards & Honors
Karen Colina Wilson Endowed Chair in Pediatric Brain Tumor Research
Professional Memberships
- American Association for Cancer Research
- American Society of Clinical Oncology
- Society of Neuro-Oncology
- American Society of Pediatric Hematology/Oncology
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 5/29/2009 the review process regarding Dr. Tekautz’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
